Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Medtronic
US Department of Justice
US Army
Daiichi Sankyo
Merck
Moodys
Fish and Richardson
Cerilliant

Generated: May 23, 2018

DrugPatentWatch Database Preview

PROPULSID Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Propulsid, and what generic alternatives are available?

Propulsid is a drug marketed by Janssen Pharms and Janssen Pharma and is included in three NDAs.

The generic ingredient in PROPULSID is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.
Summary for PROPULSID
Drug patent expirations by year for PROPULSID
Medical Subject Heading (MeSH) Categories for PROPULSID
Synonyms for PROPULSID
(.+/-.)-Cisapride
(+-)-Cisapride
104860-73-3
4-Amino-5-chloro-2-methoxy-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]benzamide
4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide
4-Amino-5-chloro-N-(1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl)-2-methoxybenzamide, cis- #
4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide
4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidyl]-2-methoxy-benzamide
4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide
4-amino-5-chloro-N-[1-{3-[(4-fluorophenyl)oxy]propyl}-3-(methyloxy)piperidin-4-yl]-2-(methyloxy)benzamide
4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide
4-AMINO-5-CHLORO-N-{1-[3-(4-FLUOROPHENOXY)PROPYL]-3-METHOXY-4-PIPERIDYL}-2-METHOXYBENZAMIDE
4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-methoxybenzamide
81098-60-4
AC-1912
AC1L1EFB
Acenalin
ACMC-20m7on
Acpulsif
AKOS005710823
Alimix
Alimix Forte
Alipride
AN-14451
BC204732
BDBM50005836
Benzamide, 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy -4-piperidinyl)-2-methoxy-, cis-
Benzamide, 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, cis-
Benzamide, 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, monohydrate, cis-
Benzamide, 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxy-, cis-
Benzamide,4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxy-
C06910
C23H29ClFN3O4.H2O
CAS-81098-60-4
CCG-213491
CHEBI:95129
CHEMBL1729
CHEMBL560739
cid_5311047
Cipride
cis-4-Amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-o-anisamide
cis-4-Amino-5-chloro-N-[1-[3-(p-fluorophenoxy)propyl]-3-methoxy-4-piperidyl]-o-anisamide
Cisaprida [INN-Spanish]
Cisaprida [Spanish]
cisapride
Cisapride (USAN/INN)
Cisapride [USAN:BAN:INN:JAN]
Cisapride prodrug (oral, ECLYPS), ProCor Pharmaceuticals
Cisapridum [INN-Latin]
Cisapridum [Latin]
Cisapron
Cisawal
Colinorm
Coordinax
CTK4A3424
D00274
D0BD8D
D0N1BQ
DCSUBABJRXZOMT-UHFFFAOYSA-N
Dispep
DSSTox_CID_2825
DSSTox_GSID_22825
DSSTox_RID_76746
DTXSID3022825
EINECS 279-689-7
Enteropride
Esorid
FT-0623916
GTPL240
Guptro
HE005238
HE391046
HMS1569E22
HMS3370F16
HSDB 3571
I01-0115
Kaudalit
KB-289943
Kinestase
L000938
LS-25437
MCULE-7144129340
MolPort-003-666-853
NCGC00016944-01
NCGC00025262-02
NCGC00168465-01
Prepulsid
Prepulsid (TN)
Prepulsid, Propulsid
Presid
Prestwick_786
Prestwick0_000430
Prestwick1_000430
Prestwick2_000430
Pridesia
Propulsid (TN)
Propulsid Quicksolv
Propulsin
Pulsid
R 51619
R-51619
R51619
Rapulid
Risamal
Risamol
SCHEMBL16131
SPBio_002359
STL058624
Syspride
T 1341
Tox21_110699
Tox21_110699_1
Unamol
Unipride
Vomiprid
Vomipride

US Patents and Regulatory Information for PROPULSID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms PROPULSID cisapride monohydrate SUSPENSION;ORAL 020398-001 Sep 15, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-001 Jul 29, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-002 Dec 23, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for PROPULSID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-002 Dec 23, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms PROPULSID cisapride monohydrate SUSPENSION;ORAL 020398-001 Sep 15, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-001 Jul 29, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Harvard Business School
QuintilesIMS
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Deloitte
Baxter
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.